Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome

Donor lymphocyte infusion has become established as a salvage therapy for patients with hematological disorders relapsing after allogeneic bone marrow transplantation (BMT). The role of donor lymphocyte infusion for patients with myelodysplastic syndrome (MDS) remains to be established. Between July...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2004-03, Vol.33 (5), p.531-534
Hauptverfasser:	DEPIL, S, DECONINCK, E, MILPIED, N, SUTTON, L, WITZ, F, JOUET, J. P, DAMAJ, G, YAKOUB-AGHA, I
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adult Anemia, Refractory, with Excess of Blasts - therapy Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blast cells Bone marrow Bone marrow transplantation Bone Marrow Transplantation - adverse effects Bone marrow, stem cells transplantation. Graft versus host reaction CD3 antigen Chemotherapy Chronic myelomonocytic leukemia Fatalities Female Graft vs Host Disease Hematologic and hematopoietic diseases Hematological diseases Histocompatibility antigen HLA Humans Leukemia, Myeloid - therapy Leukemia, Myelomonocytic, Chronic - therapy Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphocyte Transfusion Lymphocytes Male Medical sciences Middle Aged Myelodysplastic syndrome Myelodysplastic syndromes Myelodysplastic Syndromes - immunology Myelodysplastic Syndromes - therapy Patients Recurrence Refractory anemia Stem cell transplantation Tissue Donors Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation, Homologous Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!